The US has imposed sanctions on Pakistan after Islamabad refused to take back its citizen deportees and visa over-stayers from America, warning that it may withhold visas of Pakistanis beginning from its senior officials.
The State Department on Friday said that consular operations in Pakistan remain unchanged as of now but as a result of such a sanction mentioned in a Federal Register notification dated April 22, the US may withhold visas of Pakistanis beginning with its senior officials.
Pakistan is the latest to join the list of 10 nations that have been imposed with sanctions under a US law according to which countries refusing to take back deportees and visa over-stayers will be denied American visas.
Notably eight of these countries have been slapped with such visa sanctions under the Trump administration. Two of them, Ghana and Pakistan have been included in the list this year.
The other countries include Guyana in 2001, the Gambia in 2016, Cambodia, Eritrea, Guinea, and Sierra Leone in 2017, Burma and Laos in 2018.
Under Section 243 (d) of the Immigration and Nationality Act, the Secretary of State is required to discontinue granting immigration or non-immigrant visas to a nation upon receiving notice from the Homeland Security Secretary that the country has denied or is unreasonably delaying accepting a citizen, subject, national or resident of that country.
The State Department tried to downplay the impact of the sanctions on Pakistan.
Consular operations in Pakistan remain unchanged, a State Department Spokesperson told PTI when asked about the federal register notification.
This is a bilateral issue of ongoing discussion between the US and Pakistani governments and we are not going to get into the specifics at this time, the spokesperson said.
Former Pakistan's Ambassador to the US, Hussain Haqqani, feels that this will make things difficult for Pakistanis.
This measure will create hardship for Pakistanis who want or need to travel to the US and could have been avoided if Pakistani authorities had not ignored American requests to respect their legal requirements for deportation,Haqqani told PTI, days after the federal register notification.
He said that Pakistan's refusal to accept its citizens deported from the US is not new.
Pakistan's refusal to accept every Pakistani citizen deported from the US is not new. It seems that the US is no longer willing to overlook a wide range of official Pakistani behaviour. Bonhomie has been replaced by sanctions and restrictions based on Islamabad's policy decisions, Haqqani said.
Tourism Observer
Home »
cough »
diabetes »
diseases »
in general »
Phytotherapy »
skin diseases »
PAKISTAN: US Slaps Pakistan With Sanctions Over Refusal To Take Back Its Citizen Deportees
Monday, 29 April 2019
PAKISTAN: US Slaps Pakistan With Sanctions Over Refusal To Take Back Its Citizen Deportees
Tags :
cough,
diabetes,
diseases,
in general,
Phytotherapy,
skin diseases
Related : PAKISTAN: US Slaps Pakistan With Sanctions Over Refusal To Take Back Its Citizen Deportees
UAE: Passengers Face Consequential Delays As Six Air India Flights From UAE Affected By Software Glitch Flights in the Gulf region were minimally affected by the massive disruption experienced by Air India due to a server crash yesterday, an airline official said, adding ...
UAE: Flydubai Wants Compensation From Boeing And Replacement Of 737 Max Most airlines across the world grounded 737 Max after an Ethiopian Airlines jet crashed in March. Flydubai may prefer an option of replacing its order of more than 100 ...
FDA Approves Jatenzo (testosterone undecanoate) for Certain Forms of Hypogonadism The U.S. Food and Drug Administration approved Jatenzo (testosterone undecanoate), an oral testosterone capsule to treat men with certain forms of hypogonad ...
FDA Approves Sunosi Jazz Pharmaceuticals plc announced that the U.S. Food and Drug Administration (FDA) approved Sunosi (solriamfetol) to improve wakefulness in adult pat ...
Karyopharm Announces FDA Extension of Review Period for Selinexor New Drug Application Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a clinical-stage pharmaceutical company, announced that the U.S. Food and Drug Administration (FD ...
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment